Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 148 citing Robbins: Thyroid cancer: a lethal endocrine neoplasm. (0.07 sec) 

Comparison of administration of recombinant human thyrotropin with withdrawal of …


PW Ladenson, LE Braverman, EL Mazzaferri, … - The New England …, 1997 - nejm.highwire.org
Results Sixty-two of the 127 patients had positive whole-body radioiodine scans by one or both
techniques. The scans obtained after stimulation with thyrotropin were equivalent to the scans
obtained after withdrawal of thyroid hormone in 41 of these patients (66 percent), superior ...
Cited by 310 - Related articles - BL Direct - All 6 versions

Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid …


KH DOW, BR Ferrell, C Anello - Thyroid, 1997 - liebertonline.com
Page 1. THYROID Volume 7, Number 4, 1997 Mary Ann Liebert, Inc. Quality-of-Life Changes
in Patients with Thyroid Cancer After Withdrawal of Thyroid Hormone Therapy KAREN HASSEY
DOW,1 BETTY R. FERRELL,2 and CAROL ANELLO3 ABSTRACT ...
Cited by 170 - Related articles - BL Direct - All 3 versions

Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to …

- endojournals.org
GM Venkataraman, M Yatin, R Marcinek, KB … - Journal of Clinical …, 1999 - Endocrine Soc
Disseminated dedifferentiated thyroid epithelial carcinoma, which cannot sufficiently concentrate
therapeutic radioiodide, is a terminal disease without any effective systemic treatment or
chemotherapy. This is a likely consequence of loss of human sodium-iodide symporter ( ...
Cited by 138 - Related articles - BL Direct - All 5 versions

ret/PTC-1,-2, and-3 oncogene rearrangements in human thyroid carcinomas: …


SL Sugg, L Zheng, IB Rosen, JL Freeman, S … - Journal of Clinical …, 1996 - Endocrine Soc
Page 1. 0021-972x1961$03.00/0 Journal of Clinml Endocrinology and Metabolism Copyright
0 1996 by The Endocrine Society Vol. 81, No. 9 Printed in USA retlPTC-1, -2, and -3 Oncogene
Rearrangements in Human Thyroid Carcinomas: Implications for Metastatic Potential?* ...
Cited by 119 - Related articles - BL Direct - All 8 versions

Outcome after treatment of high-risk papillary and non-Hurthle-cell follicular thyroid …

- annals.org
T Taylor, B Specker, J Robbins, M Sperling, … - Annals of internal …, 1998 - Am Coll Physicians
Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook
Add to Reddit Add to Technorati Add to Twitter What's this? ... Background: Treatment of differentiated
thyroid cancer has been studied for many years, but the benefits of extensive initial ...
Cited by 113 - Related articles - BL Direct - All 3 versions

Prognosis and treatment of brain metastases in thyroid carcinoma

- endojournals.org
AC Chiu, ES Delpassand, SI Sherman - Journal of Clinical Endocrinology …, 1997 - Endocrine Soc
We analyzed 47 cases of brain metastases from thyroid cancer seen at 1 institution over 5
decades. Brain metastases were a primary clinical feature at initial presentation in 15% of the
cases, were identified during the subsequent course of the disease in 68%, and were ...
Cited by 108 - Related articles - BL Direct - All 5 versions

Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), …

- endojournals.org
M Kitazono, R Robey, Z Zhan, NJ Sarlis, MC … - Journal of Clinical …, 2001 - Endocrine Soc
Thyroid carcinoma accounts for the majority of deaths from endocrine cancers. A major cause
of treatment failure is the inability to trap iodine. Chemotherapeutic agents with differentiating
properties have been tried in an attempt to increase iodine uptake. We examined the ...
Cited by 104 - Related articles - BL Direct - All 4 versions

Current trends in the management of well differentiated papillary thyroid carcinoma


BL Solomon, L Wartofsky, KD Burman - Journal of Clinical Endocrinology …, 1996 - Endocrine Soc
Page 1. 0021-972x/96/$03.00/0 Journal of Clinical Endocrinology and Metabolism Copyright
0 1996 by The Endocrine Society Vol. 81, No. 1 Printed in USA Current Trends in the
Management of Well Differentiated Papillary Thyroid Carcinoma* ...
Cited by 102 - Related articles - All 5 versions

Molecular diagnosis of residual and recurrent thyroid cancer by amplification of …

- endojournals.org
MD Ringel, PW Ladenson, MA Levine - Journal of Clinical Endocrinology …, 1998 - Endocrine Soc
Serum thyroglobulin measurement by immunoassay is used to detect residual or recurrent thyroid
cancer after thyroid ablation. However, the usefulness of immunoassay is limited by both the
requirement for thyroid hormone withdrawal to attain optimal test sensitivity and ...
Cited by 100 - Related articles - BL Direct - All 5 versions

SERUM THYROGLOBULIN MEASUREMENT Utility in Clinical Practice


JI Torréns, HB Burch - Endocrinology and metabolism clinics of North America, 2001 - Elsevier
For many years, thyroglobulin was thought to be restricted to the thyroid gland. In 1940 Lerman
128 detected thyroglobulin in the venous efflux from the human thyroid immediately after
thyroidectomy. In 1954 Robbins 201 demonstrated thyroglobulin in the serum of patients ...
Cited by 90 - Related articles - BL Direct - All 9 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google